Vinay Prasad, M.D., has rejoined the FDA, the latest turn in a monthslong stretch of leadership turnover at the agency. | “At ...

Vinay K. Prasad, MD, MPH, a controversial hematologist-oncologist who abruptly left his two leadership roles at FDA last ...

The new FDA vaccine chief, Dr. Vinay Prasad was an outspoken critic of the agency's response to the pandemic, including the former vaccine chief, Dr. Peter Marks.

The US Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized COVID-19 restrictions, as the director of its Center for Biologics Evaluation and Research ...

The FDA has named Vinay Prasad, an oncologist who has previously criticized COVID-19 restrictions, as the director of its Center for Biologics Evaluation and Research.

Dr. Vinay Prasad, an oncologist who previously criticized the FDA and was a fierce critic of COVID-19 vaccine and mask mandates, was appointed in May.

Dr. Vinay Prasad was an outspoken critic of the FDA’s response to the pandemic, including the former vaccine chief, Dr. Peter Marks.

Dr. Vinay Prasad was an outspoken critic of the FDA’s response to the pandemic, including the former vaccine chief, Dr. Peter Marks.

Dr. Vinay Prasad was an outspoken critic of the FDA’s response to the pandemic, including the former vaccine chief, Dr. Peter Marks.

The FDA has appointed hematologist-oncologist Vinay Prasad, MD, to lead the agency’s Center for Biologics Evaluation and Research, according to a May 6 NBC News report. As the head of CBER, Dr ...

Oncologist Vinay Prasad was named the new vaccine chief by the FDA in May 2025. Here’s what you need to know.